abstract |
the present invention relates, in some embodiments, to methods for treating a neurodegenerative disease in an individual using a histone deacetylase 2 (hdac2) / sp3 inhibitor, which may be a peptide inhibitor comprising the carboxyl terminus of hdac2 and related compositions. |